Digitizing and Automating the Diagnostic Psychiatric Assessment Process
DADAP
1 other identifier
observational
35
1 country
1
Brief Summary
This is an observational study that will be responsible for the Spanish translation and cross-cultural adaptation, and validation of the Electronic Semi-Structured Psychiatric Interview for Children and Adolescents (EPSI-C), to examine, classify, prioritize, and diagnose patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2026
CompletedFirst Submitted
Initial submission to the registry
January 27, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
March 12, 2026
January 1, 2026
9 months
January 27, 2026
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Child and adolescent psychiatric assessment
EPSI-C (Electronic Semi-Structured Psychiatric Interview for Children and Adolescents). A semi-structured diagnostic interview that assesses current episodes of psychopathology in children and adolescents aged 6 to 17 years according to the DSM-5 diagnostic criteria. The mental disorders assessed by the EPSI-C are: specific phobia, separation anxiety disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder (PTSD) and complex PTSD (according to ICD-11 criteria), major and persistent depression, manic/hypomanic episode, anorexia nervosa, bulimia nervosa, binge eating disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, Tourette's disorder/tics, oppositional defiant disorder, and conduct disorder. It also includes screening for psychotic disorders and self-harm.
At baseline
Secondary Outcomes (3)
Content validity
At baseline
Patient acceptability
At baseline
Feasibility of the EPSI-C
At baseline
Eligibility Criteria
Children aged between 6 and 17 years who present a clinical demand for mental health and are referred from primary care to the community mental health center Málaga Centro.
You may qualify if:
- \- Families and children aged 6 to 17 with a mental health referral from primary care.
You may not qualify if:
- Minors under state care without stable attachment figures to report clinical history.
- Presence of global developmental disorder or moderate to severe intellectual disability.
- Incomplete, inaccurate, or unclear medical data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Plaza del Hospital Civil s/n, Pabellón 4, 1ª Planta
Málaga, Málaga, 29019, Spain
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Marina Romero-González, Doctor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Predoctoral investigator
Study Record Dates
First Submitted
January 27, 2026
First Posted
March 12, 2026
Study Start
January 9, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
March 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Data will be collected during the pilot studies and will include participants' and clinicians' comments, as well as the results of the psychiatric evaluation interview (EPSIC). All shared data will be anonymized and encrypted to ensure confidentiality and security. Participants will be informed and asked for their consent to share their data with professionals in other countries that are part of the consortium. This will be clearly explained in the informed consent and assent forms.